Branching cross-examination

This is a MedVellum formative viva. It is not an official RACP, MRCPCH, ABP, ACGME or RCPSC station, mark scheme, duration or pass standard. Release each update only after the candidate states the mechanism, the dose principle, and the safeguard. ^{[1] [4]}

Candidate brief

You are the paediatric registrar in an oncology shared-care clinic. Speak as you would when building a supportive pharmacology plan around a child on doxorubicin and cisplatin. State the toxicity, the matched antidote, and the surveillance at each step. This is one continuous case. Each escalation branch leads to the next update. ^[1]